Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Deramciclane. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1173928C reveals a novel dioxane-based process for Deramciclane intermediates, eliminating toxic DMF and suppressing ketone impurities for superior pharmaceutical manufacturing.